RubusosideCAS# 64849-39-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 64849-39-4 | SDF | Download SDF |
PubChem ID | 24721373 | Appearance | White-beige powder |
Formula | C32H50O13 | M.Wt | 642.73 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | DMSO : ≥ 32 mg/mL (49.79 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,4S,5R,9S,10R,13S)-5,9-dimethyl-14-methylidene-13-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate | ||
SMILES | CC12CCCC(C1CCC34C2CCC(C3)(C(=C)C4)OC5C(C(C(C(O5)CO)O)O)O)(C)C(=O)OC6C(C(C(C(O6)CO)O)O)O | ||
Standard InChIKey | YWPVROCHNBYFTP-OSHKXICASA-N | ||
Standard InChI | InChI=1S/C32H50O13/c1-15-11-31-9-5-18-29(2,7-4-8-30(18,3)28(41)44-26-24(39)22(37)20(35)16(12-33)42-26)19(31)6-10-32(15,14-31)45-27-25(40)23(38)21(36)17(13-34)43-27/h16-27,33-40H,1,4-14H2,2-3H3/t16-,17-,18+,19+,20-,21-,22+,23+,24-,25-,26+,27+,29-,30-,31-,32+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Rubusoside is a natural sweetener and a solubilizing agent with antiangiogenic and antiallergic properties.Rubusoside can improve the survival rate of palmitic acid- induced INS- 1 cells and inhibit the occurrence of apoptosis. |
Targets | P450 (e.g. CYP17) |
In vitro | Reformulation of etoposide with solubility-enhancing rubusoside.[Pubmed: 22698860]Int J Pharm. 2012 Sep 15;434(1-2):453-9.Etoposide (ETO), a widely used anti-cancer drug, is constrained by its low aqueous solubility and by side effects from both the drug and its solubilizing excipients. In this study, a recently discovered natural solubilizer Rubusoside (RUB) was used to achieve the solubilization of ETO. Protective Effects of Rubusoside on the Ultrastructure and Cyt C Translocation Expression of the Palmitic Acid- induced INS- 1 Cells.[Reference: WebLink]Chinese Journal of Ethnomedicine & Ethnopharmacy, 2015, 24(24):16-8.To investigate the protective mechanism of Rubusoside treating on the palmitic acid- induced INS- 1 cells. |
Structure Identification | Enzyme Microb Technol. 2014 Oct;64-65:38-43.Production of rubusoside from stevioside by using a thermostable lactase from Thermus thermophilus and solubility enhancement of liquiritin and teniposide.[Pubmed: 25152415]Solubility is an important factor for achieving the desired plasma level of drug for pharmacological response. About 40% of drugs are not soluble in water in practice and therefore are slowly absorbed, which results in insufficient and uneven bioavailability and GI toxicity. Rubusoside (Ru) is a sweetener component in herbal tea and was discovered to enhance the solubility of a number of pharmaceutically and medicinally important compounds, including anticancer compounds.
J Agric Food Chem. 2012 Jun 20;60(24):6210-6.Mass production of rubusoside using a novel stevioside-specific β-glucosidase from Aspergillus aculeatus.[Pubmed: 22530920]Rubusoside (R) is a natural sweetener and a solubilizing agent with antiangiogenic and antiallergic properties. However, currently, its production is quite expensive, and therefore, we have investigated nine commercially available glycosidases to optimize an economically viable Rubusoside-production method.
|
Rubusoside Dilution Calculator
Rubusoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.5559 mL | 7.7793 mL | 15.5586 mL | 31.1173 mL | 38.8966 mL |
5 mM | 0.3112 mL | 1.5559 mL | 3.1117 mL | 6.2235 mL | 7.7793 mL |
10 mM | 0.1556 mL | 0.7779 mL | 1.5559 mL | 3.1117 mL | 3.8897 mL |
50 mM | 0.0311 mL | 0.1556 mL | 0.3112 mL | 0.6223 mL | 0.7779 mL |
100 mM | 0.0156 mL | 0.0778 mL | 0.1556 mL | 0.3112 mL | 0.389 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- AS-605240
Catalog No.:BCC2495
CAS No.:648450-29-7
- AS-604850
Catalog No.:BCC4989
CAS No.:648449-76-7
- ophocarpine hydrobromide
Catalog No.:BCN7541
CAS No.:78003-71-1
- Vitexin-2''-O-rhamnoside
Catalog No.:BCN5025
CAS No.:64820-99-1
- Neomangiferin
Catalog No.:BCN4970
CAS No.:64809-67-2
- Heraclenol acetonide
Catalog No.:BCN4192
CAS No.:64790-68-7
- Glucagon (19-29), human
Catalog No.:BCC1012
CAS No.:64790-15-4
- Trilobatin 2''-acetate
Catalog No.:BCN4191
CAS No.:647853-82-5
- Betulalbuside A
Catalog No.:BCN4190
CAS No.:64776-96-1
- L-trans-2,4-PDC
Catalog No.:BCC6595
CAS No.:64769-66-0
- 6-Hydroxy-1,2,3,7-tetramethoxyxanthone
Catalog No.:BCN7565
CAS No.:64756-87-2
- 1,2,3,6,7-Pentamethoxyxanthone
Catalog No.:BCN7525
CAS No.:64756-86-1
- Urapidil HCl
Catalog No.:BCC5044
CAS No.:64887-14-5
- trans-Norpterosin C
Catalog No.:BCN6918
CAS No.:64890-70-6
- BAY 61-3606 dihydrochloride
Catalog No.:BCC1407
CAS No.:648903-57-5
- Boc-D-Trp(For)-OH
Catalog No.:BCC2598
CAS No.:64905-10-8
- Schisantherin D
Catalog No.:BCN7010
CAS No.:64917-82-4
- Schisantherin E
Catalog No.:BCN6766
CAS No.:64917-83-5
- Sendanolactone
Catalog No.:BCN4193
CAS No.:64929-59-5
- Schisantherin C
Catalog No.:BCN3621
CAS No.:64938-51-8
- Ditryptophenaline
Catalog No.:BCN7408
CAS No.:64947-43-9
- H-D-Asp(OtBu)-OH
Catalog No.:BCC2899
CAS No.:64960-75-4
- Brivanib (BMS-540215)
Catalog No.:BCC1231
CAS No.:649735-46-6
- Brivanib Alaninate (BMS-582664)
Catalog No.:BCC1240
CAS No.:649735-63-7
Reformulation of etoposide with solubility-enhancing rubusoside.[Pubmed:22698860]
Int J Pharm. 2012 Sep 15;434(1-2):453-9.
Etoposide (ETO), a widely used anti-cancer drug, is constrained by its low aqueous solubility and by side effects from both the drug and its solubilizing excipients. In this study, a recently discovered natural solubilizer Rubusoside (RUB) was used to achieve the solubilization of ETO. Dynamic light scattering and freeze-fracture transmission electron microscopy studies showed that ETO and RUB formed ETO-RUB nanoparticles ( approximately 6 nm in diameter). The powder of ETO-RUB nanoparticles was completely reconstitutable in water and remained stable in this solution at 25 and 37 degrees C for at least 24h. Under other physiologic conditions, ETO solution was clear and free of precipitation at 25 degrees C, but underwent various structural transformations. In PBS and simulated intestinal fluid, RUB-solubilized ETO underwent epimerization and equilibrated to cis-ETO. In simulated gastric fluid, RUB-solubilized ETO degraded to 4'-demethylepipodophyllotoxin-beta-d-glucoside and 4'-demethylepipodophyllotoxin. Higher temperatures favored epimerization or degradation. Furthermore, a side-by-side comparison with DMSO-solubilized ETO confirmed that the RUB-solubilized ETO showed no significant differences in cytotoxicity in colon, breast and prostate cancer cell lines. RUB effectively solubilized and stabilized etoposide, which sets the stage for further toxicology, bioavailability, and efficacy investigations.
Production of rubusoside from stevioside by using a thermostable lactase from Thermus thermophilus and solubility enhancement of liquiritin and teniposide.[Pubmed:25152415]
Enzyme Microb Technol. 2014 Oct;64-65:38-43.
Solubility is an important factor for achieving the desired plasma level of drug for pharmacological response. About 40% of drugs are not soluble in water in practice and therefore are slowly absorbed, which results in insufficient and uneven bioavailability and GI toxicity. Rubusoside (Ru) is a sweetener component in herbal tea and was discovered to enhance the solubility of a number of pharmaceutically and medicinally important compounds, including anticancer compounds. In this study, thirty-one hydrolyzing enzymes were screened for the conversion of stevioside (Ste) to Ru. Recombinant lactase from Thermus thermophiles which was expressed in Escherichia coli converted stevioside to Rubusoside as a main product. Immobilized lactase was prepared and used for the production of Rubusoside; twelve reaction cycles were repeated with 95.4% of Ste hydrolysis and 49 g L(-1) of Ru was produced. The optimum Rubusoside synthesis yield was 86% at 200 g L(-1), 1200 U lactase. The purified 10% Rubusoside solution showed increased water solubility of liquiritin from 0.98 mg mL(-1) to 4.70+/-0.12 mg mL(-1) and 0 mg mL(-1) to 3.42+/-0.11 mg mL(-1) in the case of teniposide.
Mass production of rubusoside using a novel stevioside-specific beta-glucosidase from Aspergillus aculeatus.[Pubmed:22530920]
J Agric Food Chem. 2012 Jun 20;60(24):6210-6.
Rubusoside (R) is a natural sweetener and a solubilizing agent with antiangiogenic and antiallergic properties. However, currently, its production is quite expensive, and therefore, we have investigated nine commercially available glycosidases to optimize an economically viable R-production method. A stevioside (ST)-specific beta-glucosidase (SSGase) was selected and purified 7-fold from Aspergillus aculeatus Viscozyme L by a two-step column chromatography procedure. The 79 kDa protein was stable from pH 3.0 to pH 7.0 at 50-60 degrees C. Hydrolysis of ST by SSGase produced R and steviol monoglucosyl ester as determined by (1)H and (13)C nuclear magnetic resonance (NMR). Importantly, SSGase showed higher activity toward ST than other beta-linked glucobioses. The optimal conditions for R production were 280 mM ST and 16.6 muL of SSGase at pH 5.1 and 63 degrees C. This is the first discussion detailing the production of R by enzymatic hydrolysis of ST and is useful for the food additive and pharmaceutical industries.